BRUSSELS (dpa-AFX) - The Swiss stock market got off to a positive start
Friday, but quickly ran out of steam and dropped solidly into negative
territory. The market was then stuck in a sideways trend for most of the
afternoon. The weak performance...
Shares of Cerulean Pharma Inc (NASDAQ: CERU) are up over 50 percent on roughly 19 times its average volumes on Wednesday.
News Behind Move
The clinical-stage company said in a Businesswire release that it has struck a strategic collaboration...
BASEL (dpa-AFX) - Novartis (NVS) announced updated results from Phase II
study (ASCEND-3), which demonstrated that anaplastic lymphoma kinase-positive
(ALK+) non-small cell lung cancer (NSCLC) patients taking Zykadia (ceritinib).
Oops! Unable to complete your request. Please refresh your browser.